NovaBay Pharmaceuticals Inc
NBY0.760USD
+0.008+1.10%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
4.57M시가총액
0.12P/E TTM
자세한 내용은 NovaBay Pharmaceuticals Inc 회사
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
NovaBay Pharmaceuticals Inc 정보
종목 코드 NBY
회사 이름NovaBay Pharmaceuticals Inc
상장일Oct 26, 2007
CEOKazley (Michael John)
직원 수14
유형Ordinary Share
회계 연도 종료Oct 26
주소2000 Powell St Ste 1150
도시EMERYVILLE
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가United States of America
우편 번호94608-1804
전화15108998800
웹사이트https://novabay.com/
종목 코드 NBY
상장일Oct 26, 2007
CEOKazley (Michael John)
NovaBay Pharmaceuticals Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
933.00
+841.00%
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
67.00
-513.00%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
-26.00%
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
933.00
+841.00%
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
67.00
-513.00%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
-26.00%
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
수익 분석
FY2025Q3
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
521.00K
0.00%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Thu, Feb 5
마지막 업데이트: Thu, Feb 5
주주
주주 유형
주주
주주
비율
R01 Fund LP
45.02%
Framework Ventures Management LLC
45.02%
Lazar (David Elliot)
5.06%
The Vanguard Group, Inc.
1.45%
Poplar Point Capital Management LLC
0.81%
기타
2.63%
주주
주주
비율
R01 Fund LP
45.02%
Framework Ventures Management LLC
45.02%
Lazar (David Elliot)
5.06%
The Vanguard Group, Inc.
1.45%
Poplar Point Capital Management LLC
0.81%
기타
2.63%
주주 유형
주주
비율
Corporation
90.04%
Individual Investor
5.07%
Investment Advisor
1.83%
Hedge Fund
0.81%
Investment Advisor/Hedge Fund
0.06%
Research Firm
0.01%
기타
2.18%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
41
3.14M
2.49%
+1.61M
2025Q3
38
1.37M
22.81%
-82.54K
2025Q2
43
1.43M
24.52%
+210.59K
2025Q1
42
1.34M
22.96%
+376.59K
2024Q4
40
546.91K
11.19%
+390.20K
2024Q3
42
126.44K
2.60%
+79.02K
2024Q2
44
12.01K
0.89%
-33.08K
2024Q1
44
12.73K
1.48%
-22.10K
2023Q4
45
34.29K
18.48%
+25.73K
2023Q3
47
15.18K
15.11%
-444.00
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
84.49K
0.07%
+84.22K
+31191.85%
Sep 30, 2025
Poplar Point Capital Management LLC
1.02M
0.81%
--
--
Oct 15, 2025
Geode Capital Management, L.L.C.
51.72K
0.04%
+17.90K
+52.92%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
날짜
배당락일
유형
비율
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
